To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

During the stressful and uncomfortable treatment for serious illness, seemingly small things can have a profound effect.

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast ...

Just over two years after she first publicly shared her diagnosis with stage 1 triple-positive breast cancer, the 51-year-old ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...